Accuracy of history, physical examination, cardiac biomarkers, and biochemical variables in identifying dogs with stage B2 degenerative mitral valve disease-Reference-Cited by-同舟云学术

Accuracy of history, physical examination, cardiac biomarkers, and biochemical variables in identifying dogs with stage B2 degenerative mitral valve disease

Published:2021-03 Issue:2 Volume:35 Page:755-770
ISSN:0891-6640
Container-title:Journal of Veterinary Internal Medicine
language:en
Short-container-title:J Vet Intern Med

Author:

Wilshaw Jenny¹^ORCID,Rosenthal Steven L.²,Wess Gerhard³^ORCID,Dickson Dave⁴^ORCID,Bevilacqua Luca⁵,Dutton Emily⁶^ORCID,Deinert Michael⁷,Abrantes Ricardo⁸,Schneider Ingo⁹,Oyama Mark A.¹⁰^ORCID,Gordon Sonya G.¹¹^ORCID,Elliott Jonathan¹²^ORCID,Xia Dong¹³^ORCID,Boswood Adrian¹^ORCID

Affiliation:

1. Department of Clinical Science and Services, Royal Veterinary College University of London London UK

2. CVCA Cardiac Care for Pets Towson Maryland USA

3. Clinic of Small Animal Medicine Ludwig‐Maximilians‐University of Munich Munich Germany

4. HeartVets Porthcawl UK

5. Stamford Veterinary Centre Lincolnshire UK

6. Cheshire Cardiology Cheshire UK

7. Fachtierarztpraxis Am Sandpfad Wiesloch Germany

8. RA Kardiologie Muehlheim am Main Germany

9. Tierarzt Ingo Schneider Nidderau Germany

10. Department of Veterinary Clinical Studies, School of Veterinary Medicine University of Pennsylvania Philadelphia Pennsylvania USA

11. College of Veterinary Medicine Texas A&M University College Station Texas USA

12. Department of Comparative Biomedical Science, Royal Veterinary College University of London London UK

13. Research Support Office, Royal Veterinary College University of London London UK

Publisher

Wiley

Subject

General Veterinary

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvim.16083

Reference61 articles.

1. Degenerative mitral valve disease: Survival of dogs attending primary-care practice in England

2. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs

3. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study—A Randomized Clinical Trial

4. Factors associated with disease progression in dogs with presumed preclinical degenerative mitral valve disease attending primary care veterinary practices in the United Kingdom

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical modeling of metabolic syndrome to study the pleiotropic effects of novel antidiabetic therapy independent of obesity;Scientific Reports;2024-09-05

2. Preclinical Modeling of Metabolic Syndrome to Study the Pleiotropic Effects of Novel Antidiabetic Therapy Independent of Obesity;2024-04-22

3. Machine Learning Techniques for Canine Myxomatous Mitral Valve Disease Classification: Integrating Anamnesis, Quality of Life Survey, and Physical Examination;Veterinary Sciences;2024-03-06

4. Self-Reported Utilization of International (ACVIM Consensus) Guidelines and the Latest Clinical Trial Results on the Treatment of Dogs with Various Stages of Myxomatous Mitral Valve Degeneration: A Survey among Veterinary Practitioners;Animals;2024-02-29

5. Self-Reported Utilization of International Guidelines for Staging Dogs with Myxomatous Mitral Valve Degeneration: A Survey among Veterinary Practitioners;Veterinary Sciences;2023-12-02